[HTML][HTML] The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome
Background Pan-genomic studies aim, for instance, at defining the core, dispensable and
unique genes within a species. A pan-genomics study for vaccine design tries to assess the …
unique genes within a species. A pan-genomics study for vaccine design tries to assess the …
[HTML][HTML] In silico functional prediction of hypothetical proteins from the core genome of Corynebacterium pseudotuberculosis biovar ovis
Corynebacterium pseudotuberculosis is a pathogen of veterinary relevance diseases, being
divided into two biovars: equi and ovis; causing ulcerative lymphangitis and caseous …
divided into two biovars: equi and ovis; causing ulcerative lymphangitis and caseous …
[HTML][HTML] Prediction of new vaccine targets in the core genome of Corynebacterium pseudotuberculosis through omics approaches and reverse vaccinology
CL Araújo, J Alves, W Nogueira, LC Pereira… - Gene, 2019 - Elsevier
Corynebacterium pseudotuberculosis is the etiologic agent of veterinary relevance
diseases, such as caseous lymphadenitis, affecting different animal species causing …
diseases, such as caseous lymphadenitis, affecting different animal species causing …
Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production
Corynebacterium pseudotuberculosis is the causative agent of several veterinary diseases
in a broad range of economically important hosts, which can vary from caseous …
in a broad range of economically important hosts, which can vary from caseous …
A comparative pan-genomic analysis of 53 C. pseudotuberculosis strains based on functional domains
Corynebacterium pseudotuberculosis is a pathogenic bacterium with great veterinary and
economic importance. It is classified into two biovars: ovis, nitrate-negative, that causes …
economic importance. It is classified into two biovars: ovis, nitrate-negative, that causes …
[HTML][HTML] Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis
Corynebacterium pseudotuberculosis (Cp) is a pathogenic bacterium that causes caseous
lymphadenitis (CLA), ulcerative lymphangitis, mastitis, and edematous to a broad spectrum …
lymphadenitis (CLA), ulcerative lymphangitis, mastitis, and edematous to a broad spectrum …
[HTML][HTML] A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis
LGC Pacheco, SE Slade, N Seyffert, AR Santos… - BMC microbiology, 2011 - Springer
Background Bacterial exported proteins represent key components of the host-pathogen
interplay. Hence, we sought to implement a combined approach for characterizing the entire …
interplay. Hence, we sought to implement a combined approach for characterizing the entire …
[HTML][HTML] An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
Abstract Background The bacterium Corynebacterium pseudotuberculosis (Cp) causes
caseous lymphadenitis (CLA), mastitis, ulcerative lymphangitis, and oedema in a number of …
caseous lymphadenitis (CLA), mastitis, ulcerative lymphangitis, and oedema in a number of …
[HTML][HTML] The pan-genome of the animal pathogen Corynebacterium pseudotuberculosis reveals differences in genome plasticity between the biovar ovis and equi …
Corynebacterium pseudotuberculosis is a facultative intracellular pathogen and the
causative agent of several infectious and contagious chronic diseases, including caseous …
causative agent of several infectious and contagious chronic diseases, including caseous …
[HTML][HTML] Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to
infect humans. An optimal treatment of infections with this pathogen is not available today …
infect humans. An optimal treatment of infections with this pathogen is not available today …